tiprankstipranks
Liquidia Technologies Inc (LQDA)
NASDAQ:LQDA
US Market
Want to see LQDA full AI Analyst Report?

Liquidia Technologies (LQDA) Blogger Opinions & Sentiment

720 Followers

Blogger Sentiment

Bullish: 75.00%
Sector Average
Bullish
LQDA Blogger sentiment is based on 4 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
75% SeekingAlpha
25% GuruFocus
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Liquidia: My Last Sell Call Backfired, But I'd Still Preach Caution On PAH Success
SeekingAlpha
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Liquidia Corporation: I Have Never Been This Bullish On A Position
SeekingAlpha
Liquidia Appears Set For Strong 2026 On Further Share Gains
SeekingAlpha
Liquidia (LQDA) Reports Strong 2025 YUTREPIA Sales and Positive Cash Flow
GuruFocus
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of LQDA?
Seeking Alpha’s Arquitos Capital Management has a Bullish Sentiment.
    What do Motley Fool contributors think of LQDA?
    Currently there's no blogger sentiment for LQDA.
    What Is LQDA’s Blogger Sentiment?
    LQDA’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for LQDA?
      The most recent blogger prediction for LQDA was made by Arquitos Capital Management, who was Bullish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          PRRUFImmutep Ltd
          PRNAFAlterity Therapeutics
          PBIGFParadigm Biopharmaceuticals
          NURPFNeuren Pharmaceuticals Limited
          MEOBFMesoblast Limited